Skip to main content

Table 1 TNM classification of DTC patients

From: Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

  T1b T2 T3 T4 Tx   N0 N1 Nx Total
Group A (30 mCi) 13 (15%) 42 (48%) 9 (10%) 0 20 (25%) 86 (100%) 46 (53%) 0 40 (47%) 86 (100%)
Group B (60 mCi) 37 (29%) 59 (46%) 11 (8%) 7 (5%) 14 (10%) 128 (100%) 74 (57%) 5 (4%) 49 (39%) 128 (100%)
Group C (100 mCi) 22 (23%) 50 (52%) 5 (4%) 7 (7%) 13 12(%) 95 (100%) 53 (55%) 13 (14%) 29 (31%) 95 (100%)
Total 72 151 25 14 47 309 173 18 118 309
Back to article page

Thyroid Research

ISSN: 1756-6614